Knights of Columbus Asset Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
IA
HWM
IAM
BWP
Knights of Columbus Asset Advisors's AXSM Position: Q2 2026 in Review
Knights of Columbus Asset Advisors reduced its Axsome Therapeutics (AXSM) stake by 28% in Q2 2026, selling an estimated $1.22M and leaving 14,071 shares worth $3.44M. The position accounts for 0.17% of the portfolio, ranked #130.
Knights of Columbus Asset Advisors first reported a position in AXSM in Q1 2020 and has held it in 16 quarters since. The position peaked at $3.62M in Q4 2025. 143 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.
- Knights of Columbus Asset Advisors held 14,071 shares of Axsome Therapeutics worth $3.44M as of Q2 2026.
- Knights of Columbus Asset Advisors sold 5,606 Axsome Therapeutics shares in Q2 2026, an estimated $1.22M.
- Axsome Therapeutics made up 0.17% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #130 holding.
- Knights of Columbus Asset Advisors first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 16 quarters since.
- Knights of Columbus Asset Advisors's Axsome Therapeutics position peaked at $3.62M in Q4 2025.
- 143 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.
Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.